
Opinion|Videos|October 18, 2024
Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results
Key Takeaways
- Regular assessment of renal function, proteinuria, and serological markers is crucial for monitoring lupus nephritis progression and treatment response.
- Long-term follow-up data offer valuable insights into the sustained efficacy and safety of lupus nephritis treatments.
Panelists discuss the differences in efficacy and safety profiles between belimumab and voclosporin for lupus nephritis (LN) and how payers are evaluating their value, including considerations of cost-effectiveness in LN management.
Advertisement
Episodes in this series

- How do you monitor patients with lupus nephritis for disease progression and treatment response? (Dr. Larranaga)
- Three-year follow-up results of voclosporin from the AURORA-2 study were
published earlier this year. What is the value of long-term follow-up data such as these in lupus nephritis? (Dr. Wells)
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
2
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
3
How Can Trauma Affect the Menopausal Transition?
4
Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD
5















































